3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
105
Leukemia
65
Burkitt Lymphoma
26
Lymphoma
18
Leukemia, Biphenotypic, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Promyelocytic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm, Residual
5
Leukemia, Myeloid, Acute
5
Down Syndrome
4
Neoplasms
3
Leukemia, T-Cell
3
Dendritic Cell Sarcoma, Interdigitating
3
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Glioblastoma
2
Thrombocytopenia
1
Rare Diseases
1
Philadelphia Chromosome
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neutropenia
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Mucositis
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Interventions
Radiotherapy
9
Cisplatin
8
Fibroblast Growth Factor 7
6
Low-Level Light Therapy
5
angiotensin I (1-7)
4
Radiation
4
Injections
4
Propolis
3
Morphine
3
Methotrexate
3
Leucovorin
3
Drug Therapy
3
Cryotherapy
3
glucarpidase
2
aluminum hydroxide, magnesium hydroxide, drug combination
2
Xylitol
2
Water
2
Radiotherapy, Intensity-Modulated
2
RRx-001
2
Probiotics
2
Pentoxifylline
2
Mouthwashes
2
Melphalan
2
Lidocaine
2
Ketamine
2
Interleukin 1 Receptor Antagonist Protein
2
Honey
2
Glutamine
2
Gabapentin
2
Fluorouracil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mucositis
×
Mercaptopurine
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed